about
How HIV takes advantage of the cytoskeleton in entry and replicationThe human formin FHOD1 contains a bipartite structure of FH3 and GTPase-binding domains required for activationHIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.The outer mucus layer hosts a distinct intestinal microbial niche.The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.D186/D190 is an allele-dependent determinant of HIV-1 Nef function.Microbial pathogenesis revealed by intravital microscopy: pros, cons and cautions.HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.HIV-1 Nef interferes with host cell motility by deregulation of Cofilin.Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef functionInhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.Preparation of Murine Submandibular Salivary Gland for Upright Intravital Microscopy.HIV-1 Nef Disrupts CD4 T Lymphocyte Polarity, Extravasation, and Homing to Lymph Nodes via Its Nef-Associated Kinase Complex InterfaceThe Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8 T cellsT cell receptor–triggered nuclear actin network formation drives CD4+ T cell effector functionsSalivary gland macrophages and tissue-resident CD8+ T cells cooperate for homeostatic organ surveillance
P50
Q27021639-CC8AB15B-CB80-41C2-A24E-5EA71772C815Q27652093-BD5F2F9E-0B6E-4539-8837-06D177C0F042Q30528243-A3C0C2E5-B728-4B05-8E61-F77A60B1D846Q30667045-DC11C7D2-6DF8-47B2-990F-18CB7673A468Q37415400-FFF1E978-EF3C-4797-B8CA-BF69756862D6Q38750197-5554617E-6603-4A8C-A2CB-9CBA06B17BEBQ38759156-8B132987-1C41-4315-8B96-F5313EBA123AQ38951336-C715BFE8-6866-44A8-BE44-BCDD9D197C79Q39741159-84E41404-1E0C-450B-B475-D5A6291D64DEQ39812147-DCD5F540-C26D-4FDA-B29C-ED72583E5383Q42413312-DB2D3DA6-6A39-4C1B-9241-CF0F252F4B07Q43808114-827E8A64-4028-442E-95DD-741F1133193BQ54204527-5AC2C7FB-63AA-4267-AFB6-7D58B2197654Q59351870-A6FFD947-2A0C-4A9D-8BE5-5613A6E426F2Q59881431-7039551C-BDFC-48FF-9642-7C8130F1CF58Q63874596-A3D8E93A-6460-41FF-BD24-29A02321565FQ91554137-72815A74-C50B-49EA-96A2-D12D5C6CA18A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2945-8536
@en
name
Bettina Stolp
@ast
Bettina Stolp
@en
Bettina Stolp
@es
Bettina Stolp
@nl
type
label
Bettina Stolp
@ast
Bettina Stolp
@en
Bettina Stolp
@es
Bettina Stolp
@nl
prefLabel
Bettina Stolp
@ast
Bettina Stolp
@en
Bettina Stolp
@es
Bettina Stolp
@nl
P214
P106
P1153
24759543800
P214
P31
P496
0000-0003-2945-8536
P735
P7859
viaf-160983154